Login to Your Account



NewCo News

AIMM Accelerates Antibody Work with Pharma Partnership

By Nuala Moran
Staff Writer

Tuesday, November 20, 2012
LONDON – Dutch start-up AIMM Therapeutics NV has inked a deal with a pharma partner, providing the means to ramp up development of its novel antibody platforms, and has attracted a leading immunologist and former head of the Novartis Institute for Biomedical Research, Jan de Vries, as CEO to spearhead that effort.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription